These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 12075067)

  • 1. Direct-to-consumer marketing.
    Weinberg SK
    N Engl J Med; 2002 Jun; 346(25):2010-2; author reply 2012-3. PubMed ID: 12075067
    [No Abstract]   [Full Text] [Related]  

  • 2. Direct-to-consumer marketing.
    Nunes JP
    N Engl J Med; 2002 Jun; 346(25):2011; author reply 2012-3. PubMed ID: 12078708
    [No Abstract]   [Full Text] [Related]  

  • 3. Direct-to-consumer marketing.
    Hurst JW
    N Engl J Med; 2002 Jun; 346(25):2011; author reply 2012-3. PubMed ID: 12078709
    [No Abstract]   [Full Text] [Related]  

  • 4. The cost and value of new medicines in an era of change. Proceedings of a symposium at the Tufts University European Center. Talloires, France. July 25-27, 2001.
    Pharmacoeconomics; 2002; 20 Suppl 3():vii-xi; 1-108. PubMed ID: 12542026
    [No Abstract]   [Full Text] [Related]  

  • 5. Analysis of Pharmaceutical Industry Marketing of Stimulants, 2014 Through 2018.
    Hadland SE; Cerdá M; Earlywine JJ; Krieger MS; Anderson TS; Marshall BDL
    JAMA Pediatr; 2020 Apr; 174(4):385-387. PubMed ID: 31961384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comment: the economics of direct-to-consumer advertising of prescription-only drugs: prescribed to improve consumer welfare?
    Rosenthal M
    J Health Serv Res Policy; 2004 Jan; 9(1):39-42; discussion 41-2. PubMed ID: 15006239
    [No Abstract]   [Full Text] [Related]  

  • 7. What is the impact of free drug samples on patients?
    Downey LV
    South Med J; 2008 Sep; 101(9):879-80. PubMed ID: 18708974
    [No Abstract]   [Full Text] [Related]  

  • 8. Role of the pharmaceutical industry in health care cost containment.
    Craine RB
    Am J Cardiol; 1985 Aug; 56(5):43C-46C. PubMed ID: 3927698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prescription drug pricing: the consumer perspective.
    Searing A
    N C Med J; 2003; 64(6):300-2. PubMed ID: 14983625
    [No Abstract]   [Full Text] [Related]  

  • 10. Pens.
    Silverberg NB
    Cutis; 2009 Dec; 84(6):291. PubMed ID: 20166568
    [No Abstract]   [Full Text] [Related]  

  • 11. America's other drug problem: how the drug industry distorts medicine and politics.
    Relman AS; Angell M
    New Repub; 2002 Dec; 227(25):27-41. PubMed ID: 12561803
    [No Abstract]   [Full Text] [Related]  

  • 12. Big bad pharma: an ethical analysis of physician-directed and consumer-directed marketing tactics.
    Connors AL
    Albany Law Rev; 2009 Sep; 73(1):243-82. PubMed ID: 20235401
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug industry is told to stop gifts to doctors.
    Pear R
    N Y Times Web; 2002 Oct; ():A1, A29. PubMed ID: 12474836
    [No Abstract]   [Full Text] [Related]  

  • 14. Folly or volley? Will a dollar $4 pill finally open the healthcare market to competitive pricing?
    Sturm AC
    Healthc Financ Manage; 2006 Nov; 60(11):120-2. PubMed ID: 17094287
    [No Abstract]   [Full Text] [Related]  

  • 15. Medical costs and the drug industry.
    Schwartz H
    Wall St J Midwest Ed; 1980 Apr; 60(132):22. PubMed ID: 10245744
    [No Abstract]   [Full Text] [Related]  

  • 16. Drug costs can be defended.
    Lee AM
    Med Mark Media; 1982 Mar; 17(3):36, 38, 40 passim. PubMed ID: 10309584
    [No Abstract]   [Full Text] [Related]  

  • 17. Sample medications and the uninsured.
    Hubbard MJ
    J Am Board Fam Pract; 2003; 16(1):87. PubMed ID: 12583660
    [No Abstract]   [Full Text] [Related]  

  • 18. An unusual business.
    Nat Biotechnol; 2015 Nov; 33(11):1113. PubMed ID: 26544121
    [No Abstract]   [Full Text] [Related]  

  • 19. The health-care nightmare: when will we awaken?
    Zerwekh JM
    Nurs Forum; 2002; 37(1):33-6. PubMed ID: 12056239
    [No Abstract]   [Full Text] [Related]  

  • 20. The rapidly increasing cost of medicines threatens the core of healthcare.
    Werkö L
    Scand Cardiovasc J; 2004 Jun; 38(3):130-1. PubMed ID: 15223707
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.